一类抗疟疾新药不仅能够杀死寄生虫,还可能恢复上一代药物“喹啉”的功效。可谓一箭双雕。几十年来,疟疾寄生虫对于人类使用的每一种药物几乎都产生了耐药性。有迹象表明,疟原虫不断产生新的耐药性,甚至对正在大量生产的最新一代药物——高效的青蒿素类药物也产生了耐药性。这一状况引起了人们的担心:或许全世界对疟原虫很快就束手无策了。为了预防发生新的耐药性,健康专家称:要 A new class of anti-malarial drugs not only kill parasites, but may also restore the efficacy of the previous generation of drugs, “quinoline.” Can be described as double-edged sword. For decades, malaria parasites have developed resistance to almost every drug used by humans. There are signs that the Plasmodium is constantly generating new resistance and even drug-resistant to the most powerful new generation drug, mass-produced artemisinin. This situation has aroused people’s concern: perhaps the world’s rapid malaria parasites do nothing. To prevent new resistance, health experts say: yes